Hello, and welcome to this special meeting of stockholders of Imricor Medical Systems, Inc. Please note that today's meeting is being recorded. During the meeting, we'll have a question and answer session. You can submit questions or comments at any time by clicking on the message icon. It is now my pleasure to turn today's meeting over to Steve Wedan, Imricor's Chair and CEO. The floor is yours. Thank you. Again, I'd like to welcome everyone to the special meeting of the stockholders of Imricor Medical Systems today. My name is Steve Wedan, Imricor's Chair and CEO. During the course of today's meeting, our stockholders and their proxies will have the opportunity to ask questions and register votes if you haven't already done so. CDI holders will also have the opportunity to ask questions, but are not entitled to vote at the meeting except as a proxy for CHESS Depositary Nominees. You can submit your questions at any time during the meeting, as outlined in our meeting guide, and I'll address these questions throughout the meeting. Voting today will be conducted by way of a poll on all items of business, and I will shortly open the voting for all resolutions. Once voting is open, if you're eligible to vote at this meeting, a polling icon will appear on your screen. Selecting the icon will open up a list of resolutions to present you with the voting options. To cast your vote, simply click on the appropriate option, and once you select an option, the vote is automatically recorded. You have the ability to change your vote at any time up until the time I declare voting closed. I'll provide the meeting with a warning before the close of voting. Please also note that there are a number of voting exclusions that apply to the resolutions being put to today's meeting, and these have been outlined in the notice of meeting. I now declare voting open on all items of business. I'd like to take a moment to introduce three of my fellow directors who are joining us today, Mark Tibbles, Anita Messal, and Peter McGregor. Online, we also have our CFO, Jonathan Gut, and Company Secretary, Kobe Li. I've been advised that a quorum is present, and therefore I declare this meeting open and authorized to transact business. Ladies and gentlemen, we now turn to formal business of the meeting. As mentioned previously, you may ask questions online during the meeting via the speech bubble icon on your screen. If eligible to vote at this meeting, you may do so up until the time I close voting by clicking on the polling icon on your screen. If you've already sent in your proxy voting instructions or voted by internet or telephone before the meeting, your shares have already been voted accordingly. Therefore, stockholders do not need to vote today unless they're voting for the first time or wanna change their previous votes. Voting is currently open for all items of business, and I will provide you with a warning before I move to close voting. Prior to commencement of the meeting, valid votes have been received, representing approximately 31.43% of Imricor's issued capital, or 47,562,421 shares of Class A common stock. As I stated in the proxy statement, I intend to vote all available undirected proxies in favor of all items. Ladies and gentlemen, a copy of the notice of meeting and proxy statement, including the explanatory memorandum, has been distributed to or made available to all stockholders and CDI holders. If you do not have a copy with you, please be reminded that you can download these documents from the ASX website. I propose that these documents be taken as read. As required by the bylaws, a copy of the full register of stockholders is available for viewing at Imricor's place of business in Burnsville and Imricor's registered address in Melbourne, Australia. You are encouraged to make prior arrangements with either myself in the U.S. or with Kobe Li, Imricor's Company Secretary in Australia, should you like to view the register. We will now move to the first item of business, ratification and approval of prior issue of shares under the September placement. I ask you to consider, and if thought fit, to pass the resolution as a separate ordinary resolution. For the purposes of ASX Listing Rule 7.4 and for all other purposes, the stockholders ratify and approve the prior allotment and issue of 7,755,391 shares of Class A common stock. The shares in the company at an issue price of AUD 0.38 per share on the terms and conditions of the accompanied explanatory memorandum. Are there any questions in relation to this resolution? Chair, there are no questions at this time. Thank you. Prior to the commencement of the meeting, the company received a combined direct and proxy votes, as shown on your screen, and I now put the resolution to the meeting and ask you to complete your voting. We will now move to the next item of business, the ratification and approval of the prior issue of convertible note and warrant. I ask you to consider, and if thought fit, to pass this resolution as a separate ordinary resolution. That for the purposes of ASX Listing Rule 7.4 and for all other purposes, the stockholders ratify and approve the prior issue of a convertible note for a purchase price of $2,325,000 to the K.A.H.R. Foundation, together with a warrant exercisable for 907,141 CHESS Depositary Interests at a price of $0.2563 per CDI on the terms and conditions in the accompanying explanatory memorandum. Are there any other questions in relation to this resolution? Chair, there are no questions at this time. Thank you, Kobe. Prior to the commencement of the meeting, the company received a combined direct and proxy votes as shown on your screen. I now put the resolution to the meeting and ask you to complete your voting. We will now move to the next and final item of business, approval of the issue of convertible note and warrant. I ask you to consider, and if thought fit, to pass the resolution as a separate ordinary resolution. That's for the purposes of ASX Listing Rule 7.1, and for all other purposes, the stockholders approve the issue of a convertible note for the purchase price of, in US dollars, $2,675,000 to the K.A.H.R. Foundation or its nominees, together with the warrant exercisable for 1,043,699 CDIs at a price of $0.2563 per CDI on the terms and conditions in the accompanying explanatory memorandum. Are there any questions in relation to this resolution? Chair, there are no questions at this time. Thank you. Prior to the commencement of the meeting, the company received combined direct and proxy votes as shown on your screen. I now put the resolution to the meeting and ask you to complete your voting. Ladies and gentlemen, that concludes our items of business. I will shortly close the voting system. Please ensure that you have cast your votes on all resolutions. I'll now pause for 90 seconds to allow you time to finalize these votes. Thank you, everyone. Voting is now closed. The voting results will be released to the ASX later today. I thank you for your time, and the time to join the board and me today. Your ongoing support is greatly appreciated, and we look forward to sharing the next phase of Imricor's journey with you all. Stay safe and well. Thank you. This concludes the meeting, and you may now disconnect.